Improving care for women with polycystic ovary syndrome
Depression is one of the leading causes of global disease burden, with a prevalence of 3%–8% worldwide. In a 2016 survey reported by the National Institute of Mental Health, the prevalence of major depressive episodes was higher in females compared with males (8.5% vs. 4.5%) and highest in Caucasians and adults between 18 and 25 years of age (1). A significant proportion of adults (64%) reported impairment with a major depressive episode, and 34% received no treatment. Among adolescent females, the prevalence of depression was 19.4%, and 60% reported receiving no treatment.
Source: fertstert.org
Improving care for women with polycystic ovary syndrome
Published in Embryology and Reproductive Medicine
More from Embryology and Reproductive MedicineMore posts in Embryology and Reproductive Medicine »
- Life after Stillbirth
- The possible impact of COVID 19 on fertility and ART
- Human embryonic stem cell–derived blastocyst-like spheroids resemble human trophectoderm during early implantation process
- What support is available for you in hospital if you lose your baby
- Estrogen receptor-α immunoreactivity predicts symptom severity and pain recurrence in deep endometriosis
Be First to Comment